Imagine eating a normal lunch, then feeling like that lunch is still sitting in your stomach six hours later — full, nauseated, occasionally vomiting up undigested food. That is daily life for the roughly 4 to 5 million Americans estimated to have gastroparesis, a chronic disorder of delayed gastric emptying without any mechanical obstruction. The condition is widely under-recognized, frequently misdiagnosed as functional dyspepsia or eating disorders, and disproportionately affects women.
About a third of cases are linked to diabetes, particularly long-standing type 1, with the rest split between idiopathic disease, post-surgical (vagal injury), post-viral, and medication-induced cases, according to the NIDDK. This guide explains how gastroparesis is diagnosed, the small but real treatment menu, and the dietary approach that often does more than any drug.
What Gastroparesis Is
Gastroparesis literally means “paralyzed stomach.” The stomach normally grinds and propels food through coordinated contractions controlled by the vagus nerve and the pacemaker cells of Cajal in the stomach wall. In gastroparesis, that motility is sluggish or absent, so food sits and ferments instead of moving into the small intestine. The result is the cardinal symptoms: early satiety, postprandial fullness, nausea, vomiting (often of food eaten hours earlier), bloating, and abdominal pain.
The diagnosis requires both delayed emptying on a gastric emptying study and the absence of mechanical obstruction on endoscopy or imaging. Severity is usually graded by symptom burden and emptying rate: mild, compensated; moderate, partially controlled; severe, gastroparetic crisis with frequent hospitalizations. For broader context, see our guide to chronic GI and metabolic conditions.
Causes
Diabetic gastroparesis is the best understood. Chronic hyperglycemia damages the vagus nerve and the pacemaker cells; the longer the diabetes and the worse the glycemic control, the higher the risk. Roughly 30 to 50 percent of patients with long-standing type 1 diabetes develop some degree of delayed emptying, though only a fraction become symptomatic.
Idiopathic gastroparesis — about a third of cases — has no identified cause. Many patients describe a viral-illness onset, suggesting post-infectious neuropathy. Other causes include vagotomy (intentional or incidental during fundoplication or bariatric surgery), Parkinson’s disease, scleroderma, hypothyroidism, and certain medications: GLP-1 receptor agonists, opioids, and anticholinergics commonly slow emptying. With GLP-1 use exploding, drug-induced delayed emptying has become an increasingly common clinical scenario.
How Gastroparesis Is Diagnosed
The gold standard is a four-hour solid-phase gastric emptying scintigraphy. The patient eats a standardized meal (typically egg whites with radioisotope tracer) and is imaged at 1, 2, and 4 hours. Retention greater than 60 percent at 2 hours or greater than 10 percent at 4 hours confirms delayed emptying. Newer tests include the wireless motility capsule (SmartPill) and 13C-octanoate breath test.
Workup also includes upper endoscopy to rule out obstruction, abdominal imaging if anatomy is uncertain, hemoglobin A1c (because uncontrolled hyperglycemia falsely worsens emptying tests), TSH to exclude hypothyroidism, and morning cortisol if Addisonian features are present. According to ACG guidelines, a thorough exclusion of mechanical and metabolic mimics is essential before settling on a gastroparesis diagnosis.
Dietary Management
Diet is the single highest-impact intervention. The goal is to reduce gastric workload: smaller, more frequent meals (5 to 6 per day instead of 3); low-fat content (fat slows emptying further); low-fiber, especially low-insoluble fiber; and avoidance of large salads, raw vegetables, and tough meats. Liquids empty faster than solids in most gastroparetic stomachs, so blended foods, smoothies, and nutrition shakes are often tolerated when solid meals are not.
A registered dietitian familiar with gastroparesis is genuinely useful. Nutritional deficiencies are common — B12, iron, vitamin D, and calcium need monitoring. The “gastroparesis diet” is restrictive enough that micronutrient supplementation is often needed.
When to seek emergency care: Call 911 or go to the nearest emergency room if you experience persistent vomiting preventing fluid intake for more than 24 hours, severe dehydration with confusion or fainting, vomiting blood or coffee-ground material, signs of severe diabetic ketoacidosis (rapid breathing, fruity breath, altered mental state), or rigid abdomen with severe pain that may signal bezoar perforation.
Medications
Drug therapy in gastroparesis is limited. Metoclopramide, a dopamine antagonist with prokinetic activity, is the only FDA-approved gastroparesis medication. It carries a black box warning for tardive dyskinesia, especially after more than three months of use, so dosing is typically capped at 10 mg three to four times daily for 12-week courses. Erythromycin, a macrolide antibiotic with motilin agonist activity, is widely used off-label but tachyphylaxis develops quickly.
Domperidone is more effective and better tolerated than metoclopramide in many studies but is not FDA-approved in the US — it’s available through an FDA expanded access IND or from compounding pharmacies. Prucalopride (Motegrity), approved for chronic constipation, has shown benefit in gastroparesis off-label. Antiemetics — ondansetron, prochlorperazine, scopolamine, low-dose mirtazapine — manage nausea regardless of cause. Tricyclic antidepressants at low doses help pain symptoms similar to their use in irritable bowel syndrome.
Procedural and Surgical Options
Patients who fail diet and medications have several escalation options. Gastric peroral endoscopic myotomy (G-POEM, also called POP) is an endoscopic procedure that cuts the pyloric muscle to ease gastric emptying. Response rates are 60 to 80 percent in published series, with effects lasting at least 1 to 2 years. It is now offered at many academic centers.
Gastric electrical stimulation (Enterra, the “gastric pacemaker”) delivers low-energy pulses to the stomach wall via an implanted device. Symptom response — particularly for nausea and vomiting — runs 50 to 60 percent in selected patients. Pyloroplasty and partial gastrectomy are reserved for severe refractory cases.
Enteral feeding via jejunostomy bypasses the failing stomach for the most severe patients. Total parenteral nutrition is a last resort. According to Cleveland Clinic, advanced therapies should be coordinated through gastroparesis-experienced centers given the heterogeneous response.
Glycemic Control in Diabetic Gastroparesis
Diabetic gastroparesis creates a vicious cycle: high glucose slows emptying, slow emptying makes glucose timing unpredictable, and erratic glucose worsens neuropathy. Continuous glucose monitoring is particularly valuable. Pre-meal insulin timing often needs adjustment — sometimes given after meals rather than before, since absorption is delayed. Tight A1c control (under 7 percent where safe) reduces progression of neuropathic complications.
When to See a Doctor
Persistent nausea, vomiting of undigested food eaten hours earlier, or unexplained weight loss should prompt a gastroenterology referral. If you have diabetes plus poorly controlled glucose despite seemingly correct dosing, gastroparesis is worth investigating. Don’t accept “anxiety” or “just an eating issue” without an emptying study and an endoscopy.
Frequently Asked Questions
Can gastroparesis be cured?
Most cases are managed rather than cured. Post-viral idiopathic cases sometimes resolve over 1 to 2 years. Diabetic gastroparesis tends to be chronic but may improve with prolonged tight glycemic control. G-POEM has produced sustained remission in subsets of refractory patients.
Are GLP-1 medications causing gastroparesis?
GLP-1 receptor agonists slow gastric emptying as a mechanism. In susceptible patients, this can produce or worsen gastroparesis-like symptoms. Most cases improve after stopping the medication, though some persist longer than expected. The FDA added gastroparesis-related warnings to GLP-1 labeling in 2023.
What is a bezoar?
A bezoar is a mass of undigested food (or hair, fiber, or medication) that accumulates in the stomach. They are more common in gastroparesis because of poor mixing and emptying. Bezoars can cause obstruction or perforation and may need endoscopic removal.
How does gastroparesis differ from cyclic vomiting?
Gastroparesis produces near-daily symptoms with delayed emptying. Cyclic vomiting syndrome causes discrete episodes of vomiting separated by symptom-free intervals, and emptying studies are typically normal between episodes. The two can coexist in some patients.
What to Do Next
If gastroparesis is in the differential, get the gastric emptying study before starting empiric prokinetics — diagnosis matters for both prognosis and insurance coverage of advanced therapies. If you’re already diagnosed and stuck on metoclopramide and ondansetron, ask about G-POEM at a major medical center. The procedural toolkit has expanded substantially since 2018, and patients who plateau on conservative care often benefit from a tertiary referral.